1. Lopez, Adam M, Chuang, Jen-Chieh, Turley, Stephen D. 2017. Impact of loss of SOAT2 function on disease progression in the lysosomal acid lipase-deficient mouse. In Steroids, 130, 7-14. doi:10.1016/j.steroids.2017.11.015. https://pubmed.ncbi.nlm.nih.gov/29246491/
2. Zhang, Jun, Sawyer, Janet K, Marshall, Stephanie M, Brown, J Mark, Rudel, Lawrence L. 2014. Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2. In Circulation research, 115, 826-33. doi:10.1161/CIRCRESAHA.115.304378. https://pubmed.ncbi.nlm.nih.gov/25239141/
3. Melchior, John T, Olson, John D, Kelley, Kathryn L, Link, Kerry M, Rudel, Lawrence L. 2015. Targeted Knockdown of Hepatic SOAT2 With Antisense Oligonucleotides Stabilizes Atherosclerotic Plaque in ApoB100-only LDLr-/- Mice. In Arteriosclerosis, thrombosis, and vascular biology, 35, 1920-7. doi:10.1161/ATVBAHA.115.305747. https://pubmed.ncbi.nlm.nih.gov/26229140/
4. Lopez, Adam M, Posey, Kenneth S, Turley, Stephen D. 2014. Deletion of sterol O-acyltransferase 2 (SOAT2) function in mice deficient in lysosomal acid lipase (LAL) dramatically reduces esterified cholesterol sequestration in the small intestine and liver. In Biochemical and biophysical research communications, 454, 162-6. doi:10.1016/j.bbrc.2014.10.063. https://pubmed.ncbi.nlm.nih.gov/25450374/
5. Pramfalk, Camilla, Eriksson, Mats, Parini, Paolo. 2014. Role of TG-interacting factor (Tgif) in lipid metabolism. In Biochimica et biophysica acta, 1851, 9-12. doi:10.1016/j.bbalip.2014.07.019. https://pubmed.ncbi.nlm.nih.gov/25088698/
6. Yap, Chui Sun, Sinha, Rohit Anthony, Ota, Sho, Katsuki, Masahito, Yen, Paul Michael. 2013. Thyroid hormone negatively regulates CDX2 and SOAT2 mRNA expression via induction of miRNA-181d in hepatic cells. In Biochemical and biophysical research communications, 440, 635-9. doi:10.1016/j.bbrc.2013.09.116. https://pubmed.ncbi.nlm.nih.gov/24103759/
智鼠故事 
